Objective To discuss the pathology features, pathology diagnose as well as the differential diagnosis of the testicular diffuse large B-cell lymphoma. 目的探讨睾丸弥漫性大B细胞淋巴瘤的临床病理学特点、病理诊断及鉴别诊断。
Immunohistochemical analysis confirmed that all the cases were B-cell lymphoma. 免疫组织化学检测证实均为B细胞淋巴瘤。
The treatment options for this group of patients are described in the NCCN Treatment Summary for diffuse large B-cell lymphoma. 对这部分患者的治疗方法详见NCCN弥漫大B淋巴瘤治疗总结部分。
Analysis of imaging characteristics of B-cell non-hodgkin lymphoma of skull base ( reports of 2 cases) 颅底B细胞性非霍奇金淋巴瘤的影像学特征分析(附2例报告)
The cancer vaccines rely on a biological quirk of follicular B-cell lymphoma, which is a type of non-Hodgkin's lymphoma. 滤泡性B细胞淋巴瘤是一种非霍奇金淋巴瘤,肿瘤疫苗是治疗是根据肿瘤细胞的生物学特殊性。
HIV; B lymphocytes; Immune activation; B-cell exhaustion; Highly active antiretroviral therapy; HIV;B淋巴细胞;免疫活化;功能耗竭;高效抗逆转录病毒治疗;
This identified an unexpectedly high frequency of mutations involving genes that function as master regulators of normal B-cell development and differentiation. 他们确定了一个基因的意外高频突变,此基因是正常B细胞发生和分化的主要调节基因。
Relationship between bcl-2 Gene Translocation 、 Amplification and Diffuse Large B-Cell Lymphoma bcl-2基因易位及扩增与弥漫性大B细胞淋巴瘤的关系研究
Comparison of Rituximab plus CHOP regimen and CHOP regimen alone for treatment of patients with aggressive B-cell lymphoma 美罗华联合CHOP方案与CHOP方案治疗侵袭性B细胞性淋巴瘤的临床对比研究
Cost-effectiveness Analysis of CHOP and R-CHOP Regimen for Native Diffuse Large B-cell Lymphoma CHOP和R-CHOP方案治疗弥漫性大B细胞淋巴瘤的成本-效果分析
Multiple myeloma ( MM) is an incurable clonal B-cell malignancy with terminally differentiated plasma cells. 多发性骨髓病(MM)是一种浆细胞异常增生的难治愈的B细胞恶性肿瘤。
The Analysis of Prognostic Factors in 70 Cases of Diffuse Large B-cell Lymphoma 70例弥漫大B细胞淋巴瘤相关预后因素的分析
Expression of CD10 、 BCL-6 、 MUM1 and NF-kB in Diffuse Large B-cell Lymphoma and It's Significance CD10、BCL-6、MUM1和NF-kB在弥漫大B细胞淋巴瘤中表达及其意义
Flow cytometric assessment of B-cell lymphoma 流式细胞仪免疫分型在B细胞淋巴瘤诊断中的应用
This study was to investigate the efficacy and safety of rituximab-containing regimens for patients with indolent B-cell lymphoma in China. 本研究目的是观察含美罗华方案治疗我国惰性淋巴瘤的疗效和安全性。
Establishing SCID mouse models of B-cell non-Hodgkin's lymphoma B细胞非霍奇金淋巴瘤小鼠模型的建立
The clinical study of CHOP combined with Rituximab in treating B-cell non-Hodgkin lymphoma 美罗华联合CHOP治疗B细胞性非霍奇金淋巴瘤的临床研究
Distinct Distributions of Immunohistochemical Subgroups, Cytogenetic Profiles and BCL2 Expression Mechanism of Diffuse Large B-cell Lymphoma in Chinese Patients 中国人弥漫性大B细胞淋巴瘤免疫学亚型、遗传学异常和BCL2蛋白表达机制的研究
Micronodular T-cell/ histiocyte-rich B-cell Lymphoma in Spleen: Study of the Immunophenotype and Gene Rearrangement 脾脏微结节性富于T细胞/组织细胞的B细胞淋巴瘤&免疫表型及基因重排研究
Study on Cell Growth Control of B-cell Non-Hodgkin Lymphoma by B Lymphocyte Stimulator B淋巴细胞刺激因子对B细胞非霍奇金淋巴瘤细胞生长调控的研究
They were working on a type of cancer known as follicular B-cell lymphoma, a kind of non-Hodgkin's lymphoma that attacks the immune system. 他们正在研究一种称为滤泡型B细胞淋巴瘤,它是攻击机体免疫系统的非何杰金(氏)淋巴瘤。
Objective This study is to analyze the clinical characteristics of nodal, extranodal and Waldeyer's ring diffuse large B-cell lymphoma ( DLBCL). 目的回顾性分析不同原发部位(韦氏环、结内与结外)弥漫性大B细胞淋巴瘤(DLBCL)的临床特征和预后。
Expression and Significance of Pokemon in Diffuse Large B-Cell Lymphoma and Multiple Myeloma Pokemon在弥漫性大B细胞淋巴瘤和多发性骨髓瘤中的表达和意义
Objective To evaluate the efficacy and toxicity of combination of Rituximab and CHOP regimen in diffuse large B-cell lymphoma ( DLBCL). 目的研究利妥昔单抗联合CHOP方案治疗弥漫大B细胞型淋巴瘤的疗效和不良反应。
This is a diffuse large B-cell lymphoma with high proliferative activity. 弥漫大B细胞淋巴瘤,来源于生发中心外活化的B细胞。
Objective To explore the nursing of medication before accepting131I-Rituximab radioimmunoscinitigraphy in patients with B-cell lymphoma. 目的探讨B细胞淋巴瘤131I-美罗华放免显像前用药的护理。
Nursing Care for Patients with B-Cell Non-Hodgkin's Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation Combined with Rituximab 2例B细胞非霍奇金淋巴瘤患者异基因造血干细胞移植联合利妥昔单抗治疗的护理